PASG Earnings

Quarterly EPS
$-6.15
Q3 2024
$-1.42
Q4 2024
$-4.87
Q1 2025
$-2.96
Q2 2025
$-2.44
Q3 2025
$-4.08
Q4 2025
$-2.36
Q1 2026
$-2.44
Q2 2026
Latest RevenueN/A
Latest Net Income-7821000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$2.440-7821000+17.6%
Q1 2026-$2.360-7559000+51.5%
Q4 2025-$4.080-12983000-187.3%
Q3 2025-$2.440-7749000+60.3%
Q2 2025-$2.960-9385000+41.8%
Q1 2025-$4.870-15405000+18.8%
Q4 2024-$1.420-12725000+76.8%
Q3 2024-$6.150-19340000+37.2%
Q2 2024-$5.090-15991000
Q1 2024-$6.000-16711000
Q4 2023-$6.110-16758000
Q3 2023-$9.800-27110000
Passage Bio (PASG) — Earnings